Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks To Open Higher Ahead Of BoE Minutes

Wed, 22nd Oct 2014 06:35

LONDON (Alliance News) - UK stocks are set to open higher Wednesday, following gains made in the US and Asia and ahead of the release of the minutes from the October meeting of the Monetary Policy Committee of the Bank of England.

Futures indicate the FTSE 100 will open 20 points higher at 6,392.

The UK's leading index, along with other major European indices, made significant gains on Tuesday amid reports that the European Central Bank is looking to take further steps to boost the slowing eurozone economy. Reuters reported that the ECB is considering buying bonds in the secondary market as part of its effort to boost lending in the single currency block. The central bank could take a decision as soon as December, Reuters said.

"The fact that story pushed equities up should be further evidence that it is central banks, not fundamentals, driving market momentum at the moment," says Rabobank analyst Michael Every.

Equity markets have seen a significant increase in volatility recently as investors show their nervousness over whether the global economy is strong enough to stand on its own two feet, without the extra support of the US quantitative easing programme that ends this month.

Hope of further stimulus was enough to help US investors look past mixed earnings and push Wall Street higher. The DJIA gained 1.3% higher, the S&P 500 2.0%, and the Nasdaq Composite 2.4%.

US Technology bellwether Yahoo Inc beat estimates on Tuesday by reporting third quarter earnings per share of USD0.52, much better than the USD0.30 that had been forecast by analysts. The profit includes a 6.3-billion-dollar gain from Yahoo's sale of a stake in the Alibaba Group, as part of the Chinese company's initial public offering in September.

Not all US earnings were so positive however, with McDonald's Corp, for example, reporting earnings per share of USD1.09 in the third quarter, down from USD1.52 last year and missing expectations for USD1.37.

It has been a positive Asian session so far Wednesday, with the Nikkei closing up about 2.5%, while the Hang Seng continues up 1.4%, and the Shanghai Composite is fractionally higher.

The domestic economic focus in the UK Wednesday is the release of the minutes from the latest MPC meeting at the Bank of England. The committee elected to keep the UK base rate on hold at a record low of 0.5% at the meeting earlier this month, but given that two of its members voted for a rate rise in September, investors will be keen to see how the vote was split this month. Given the recent market volatility, calls for rate rises have been somewhat subdued and the consensus expectation is for an unchanged 7-2 vote to keep rates on hold.

One of BoE's most notable hawks, Martin Weale, will be speaking after the market close at 2000 BST in Cambridge. Weale and Ian McCafferty were the two Monetary Policy Committee members to vote for a rate rise last month.

From the UK corporate calendar Wednesday, British American Tobacco has joined the list of names highlighting the impact of the strength of the pound on its earnings. The cigarette maker said its nine-month revenue was up 2.4% at constant exchange rates but down 9.6% at actual rates.

Updates are also out Wednesday from Playtech, International Personal Finance, and Spirit Pub Co. GlaxoSmithKline is reporting third-quarter earnings at 1200 BST.

In the afternoon, the attention will shift to the US where third quarter earnings season continues with a multitude of names including AT&T Inc and Boeing Company reporting.

US consumer price inflation at 1330 BST will be of key interest given the heightened concerns over the strength of the economy as stimulus is withdrawn. The expectation is for a slight fall in CPI to 1.6% year-on-year in September, from 1.7% in August. The US, like the UK, targets 2.0% inflation, and anything greater than the expected 0.1% fall will likely cause some concern, analysts say.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.